APA (7th ed.) Citation

Kimura, T., Kato, Y., Ozawa, Y., Kodama, K., Ito, J., Ichikawa, K., . . . Nomoto, K. (2018). Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model. Cancer science, 109(12), 3993-4002. https://doi.org/10.1111/cas.13806

Chicago Style (17th ed.) Citation

Kimura, Takayuki, et al. "Immunomodulatory Activity of Lenvatinib Contributes to Antitumor Activity in the Hepa1‐6 Hepatocellular Carcinoma Model." Cancer Science 109, no. 12 (2018): 3993-4002. https://doi.org/10.1111/cas.13806.

MLA (9th ed.) Citation

Kimura, Takayuki, et al. "Immunomodulatory Activity of Lenvatinib Contributes to Antitumor Activity in the Hepa1‐6 Hepatocellular Carcinoma Model." Cancer Science, vol. 109, no. 12, 2018, pp. 3993-4002, https://doi.org/10.1111/cas.13806.